scispace - formally typeset
G

Göran K. Hansson

Researcher at Karolinska University Hospital

Publications -  418
Citations -  61147

Göran K. Hansson is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Inflammation & Immune system. The author has an hindex of 107, co-authored 414 publications receiving 56595 citations. Previous affiliations of Göran K. Hansson include Sahlgrenska University Hospital & Royal Swedish Academy of Sciences.

Papers
More filters
Journal ArticleDOI

Inflammation, Atherosclerosis, and Coronary Artery Disease

TL;DR: The evidence is recounted that atherosclerosis, the main cause of CAD, is an inflammatory disease in which immune mechanisms interact with metabolic risk factors to initiate, propagate, and activate lesions in the arterial tree.
Journal ArticleDOI

Progress and challenges in translating the biology of atherosclerosis

TL;DR: Understanding how to combine experimental and clinical science will provide further insight into atherosclerosis and could lead to new clinical applications.
Journal ArticleDOI

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Morteza Naghavi, +63 more
- 07 Oct 2003 - 
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Journal ArticleDOI

The immune response in atherosclerosis: a double-edged sword

TL;DR: This Review focuses on the role of immune mechanisms in the formation and activation of atherosclerotic plaques, and also includes a discussion of the use of inflammatory markers for predicting cardiovascular events.
Journal ArticleDOI

The immune system in atherosclerosis.

TL;DR: Innate as well as adaptive immune responses have been identified in atherosclerosis, with components of cholesterol-carrying low-density lipoprotein triggering inflammation, T cell activation and antibody production during the course of disease.